Article
Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.
BMC medical genetics - 12 Jan 2010
Rasmussen Astrid, Alonso Elisa, Ochoa Adriana, De Biase Irene, Familiar Itziar, Yescas Petra, Sosa Ana-Luisa, Rodríguez Yaneth, Chávez Mireya, López-López Marisol, Bidichandani Sanjay I
Abstract excerpt
BACKGROUND: von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations in the VHL gene. Patients have significant morbidity and mortality secondary to vascular tumors. Disease management is centered on tumor surveillance that allows early detection and treatment....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.